 Home > Medical News > Latest Medical News > After the national smog, the market for anti-thrombotic varieties has changed dramatically!

After the national smog, the market for anti-thrombotic varieties has changed dramatically!

 Last Update: 2021-08-26
 Source: Internet
 Author: User

Tags

factory

data analysis systems

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Since the state organized the "4+7" drug centralized procurement in December 2018, China has organized five batches of drug procurement, and a total of 218 drugs have been successfully purchased

There are three antithrombotic drugs that have won the bid in the first four batches, namely: the first batch of clopidogrel bisulfate tablets, the third batch of apixaban tablets and ticagrelor tablets

Clopidogrel Bisulfate Tablets

Latecomers choose the opportunity to bid to enter

Purchases will begin in the fourth quarter of 2020.

How to avoid low-price competition

From the perspective of the market structure of the above three antithrombotic drugs after winning the bids, the finalists of centralized procurement are the top priority for manufacturers

Therefore, this is a war without gunpowder, and every pharmaceutical company must pay attention to it
.
For companies, they need to use product pipelines and product echelons to hedge against the risk of a single product that may lose bids or significantly reduce prices.
At the same time, in the face of the continued decline in terminal prices, companies need to increase the control of upstream raw materials to control costs.
In the long run It seems to be advanced to high-end generic drugs or modified formulations in order to avoid low-price competition
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.